50 closest statements
by meaning · ranked by similarity · 100 per pageMeaning search returns the 50 nearest statements, then applies your filters.
“The Company’s mission is to revolutionize early detection of a wide array of animal related abnormalities.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-01-1389% match
“Our mission is to power precision proteomics to enable the earliest detection of disease.”In use 2026 – now·1 sighting·SEC Form 424B4, filed 2026-04-1769% match
“Our mission is to enhance disease diagnosis by applying cutting-edge genetic diagnostic technologies, enabling earlier and more accurate detection for timely and improved treatment.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-3169% match
“Our mission is to become the leading worldwide provider of animal health products and services in the production animal and companion animal health products markets.”In use 2010 – now·1 sighting·SEC Form 10-K, filed 2010-09-1067% match
“Our mission is to ‘democratize’ genetic analysis research with products that enable customers to detect and analyze complex genetic diseases by ultra-sensitive screening and monitoring of cell-free genomic targets.”In use 2015 – now·1 sighting·SEC Form S-1/A, filed 2015-03-3167% match
“Our mission is to boldly innovate to create trusted solutions that detect, predict, and prevent disease.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1967% match
“Our mission is to detect cancer early, when it can be cured.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1266% match
“Our mission is to afford early non-invasive detection of possible physical abnormalities including breast growths, testicular growths, blood flow and more.”In use 2026 – now·1 sighting·SEC Form 20-F/A, filed 2026-05-0666% match
“Our mission is to develop and manufacture intelligent diagnostic solutions that transform the power of diagnostics into a healthier future for everyone.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-02-2365% match
“Our mission is to detect cancer and disease at earlier, more treatable stages by making screening easy and accessible.”In use 2026 – now·1 sighting·SEC Form S-1, filed 2026-08-1865% match
“Our mission is to become the world’s leading provider of innovative products and combined solutions for agriculture and environmental health.”In use 2005 – now·1 sighting·SEC Form 20-F, filed 2005-03-1565% match
“Our mission is to leverage our proprietary highly productive, and scalable microbial fungal protein production platforms to meet the growing demand for proteins in both human and animal health markets worldwide.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-2865% match
“Our mission is to change the global diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-04-0765% match
“Our mission is to enable customers across the continuum of molecular research and clinical testing to unlock valuable insights faster, better and more efficiently - from the raw biological sample to the final interpreted results.”In use 2022 – now·1 sighting·SEC Form 20-F, filed 2022-03-1464% match
“Our mission is to improve the treatment and detection of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-12-0364% match
“Our purpose is to create scientifically-proven and practical products that improve animal health and productivity in the dairy and beef industries.”In use 2016 – now·1 sighting·SEC Form 10-K, filed 2016-03-2564% match
“Our mission is to enable healthier lives as the premier provider of innovative genetic information with an exceptional customer experience.”In use 2016 – now·1 sighting·SEC Form 10-K, filed 2016-03-0364% match
“Our mission is to provide the best products, services, and technology to our Customers across the globe, so they can deliver exceptional care to their Animal Owners when and where it is needed.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-02-2864% match
“Our mission is to accelerate the discovery, development and global access to targeted radioligand therapies.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2764% match
“Our mission is to be the leading company in fueling a brighter future for global food and animal safety and security.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-07-3064% match
“Our mission is to enrich the lives of the animals we love and the veterinarians that care for them by providing products and technologies that improve patient care and enhance the economic health of veterinary practices.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1664% match
“Our mission is to transform the field of proteomics by broadening access to high-quality proteomic data and to help support fundamental advancements across human health and medicine.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2664% match
“Our mission is to improve health with technologies that transform the way that antibody-based therapies are discovered.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-02-2564% match
“The Company’s mission is to harness the full potential of FRT to provide accurate and beneficial information to companies, organizations, and society at large.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-04-2363% match
“Our mission is to expand access to novel molecular diagnostic testing, most immediately in the transplanted organ rejection testing category.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-2663% match
“Our mission is to save lives and improve outcomes for millions of people and animals worldwide.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-3063% match
“Our mission is to advance and grow a portfolio of innovative, early-stage oncology assets based on the latest scientific breakthroughs focused on overcoming immune resistance and expanding the addressable patient population.”In use 2023 – now·1 sighting·SEC Form 20-F, filed 2023-07-3163% match
“Our mission is to leverage our unique insights into the chromatin regulatory system to pioneer the discovery, development and commercialization of a new class of therapies that transform the lives of patients suffering from a wide spectrum of diseases with high unmet need.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1163% match
“Our mission is to offer an ecosystem of innovative discovery and translational research solutions that enable our customers to map the universe of biology and conduct scientific exploration that may lead to new therapies to improve the human condition.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-02-2863% match
“The Company’s mission is to improve lives through product innovation, research and development and outstanding patient and consumer experience.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-1363% match
“Our mission is to accelerate proteomics together.”In use 2021 – now·1 sighting·SEC Form 424B4, filed 2021-07-1663% match
“Our mission is to build the world’s leading endocrine company that pioneers new therapeutics to help patients better control their disease and improve their daily lives.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2663% match
“Our mission is to be the best resource to the animal health profession by delivering superior value, efficiency and innovation.”In use 2014 – now·1 sighting·SEC Form 10-K, filed 2014-11-2663% match
“Our mission is to profitably accelerate drug discovery.”In use 2005 – now·1 sighting·SEC Form 10-K/A, filed 2005-04-2963% match
“Our mission is to accelerate innovation in life sciences and thereby positively impact patient lives globally.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1162% match
“Our mission is to deliver safe and effective therapeutics that elevate the standard of care in veterinary medicine by working with companion animal veterinarians to bring new therapeutics to market that support pets and their owners.”In use 2018 – now·1 sighting·SEC Form 10-K, filed 2018-03-1462% match
“Our mission is to transform the lives of patients living with devastating genetic diseases by building the leading integrated genetic medicine company focused on developing and commercializing potentially curative therapeutics based on our GeneRide platform.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-03-1562% match
“Our mission is to commercialize lifesaving, mobile breath sensor technologies that enable professionals to more efficiently screen for the earliest signs of disease or the presence of drugs, enabling improved health outcomes, traffic safety and significant cost reduction.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-05-0562% match
“The Company's mission is to identify, develop and commercialize specialty pharmaceutical products that exceed the expectations of patients, customers and stockholders with a high-performance culture and preeminent ethical standards.”In use 2018 – now·1 sighting·SEC Form 10-K, filed 2018-03-0862% match
“Our mission is to become the leading company in precision genetic medicines by discovering, developing, manufacturing, and ultimately commercializing a new class of medicines through our proprietary base editing technology, with the goal of providing life-long cures to patients suffering from serious diseases.”In use 2020 – now·1 sighting·SEC Form 424B4, filed 2020-10-0162% match
“Our mission is to facilitate the stabilization, security and growth of the cardiac PET industry by providing cardiologists with: an economical, high-quality, PET imaging system; a reliable supply of radiopharmaceuticals for imaging procedures, and a comprehensive clinical, technical, support and service program.”In use 2015 – now·1 sighting·SEC Form 10-K, filed 2015-03-3162% match
“Our mission is to transform the way the world sees the genome through optical genome mapping (“OGM”) solutions, diagnostic services and software.”In use 2026 – now·1 sighting·SEC Form S-1, filed 2026-10-2762% match
“Our mission is to discover and develop a pipeline of EPBs to treat a broad range of diseases and disorders, with an initial focus on cancers with a high unmet medical need.”In use 2022 – now·1 sighting·SEC Form 20-F, filed 2022-04-2662% match
“Our mission is to address the pervasive problem of cancer misdiagnoses by developing solutions in the form of diagnostic products and services.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-2762% match
“Our mission is to become a global leader in developing better and safer radioimmunotherapy and antibody-based oncology therapies addressing clear unmet medical needs and, as such, have a transformational impact on the lives of patients.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-0462% match
“Our mission is to advance the understanding of fibrosis by building a biology-, chemistry- and screening- based engine to drive drug development across the spectrum of fibrotic diseases.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-0162% match
“Our mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-2762% match
“Our mission is to continually apply our scientific research to the more effective management of zoonotic diseases and, in so doing, realize the commercial potential of our molecular biotechnologies.”In use 2023 – now·1 sighting·SEC Form 10-K/A, filed 2023-02-0162% match
“Our mission is to create long-term stockholder value by acquiring, developing and commercializing innovative products for the treatment of a variety of human diseases that address important unmet medical needs or offer improved, cost-effective alternatives to current methods of treatment.”In use 2014 – now·1 sighting·SEC Form 10-K, filed 2014-03-1162% match
“Our mission is to empower physicians to positively impact patient care through the delivery of innovative molecular diagnostics services.”In use 2013 – now·1 sighting·SEC Form 10-K, filed 2013-03-2562% match
Showing 1–50 of 50